Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Psychemedics Q1 EPS $0.01, Same YoY

Psychemedics (NASDAQ:PMD) reported quarterly earnings of $0.01 per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

May 10, 2022

1 minute read

Psychemedics (NASDAQ:PMD) reported quarterly earnings of $0.01 per share. This is unchanged from the same period last year.

Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $150

By Benzinga Newsdesk

Today, 11:24 AM

Deutsche Bank analyst Pito Chickering maintains ModivCare (NASDAQ:MODV) with a Buy and lowers the price target from $180 to $150.

MODV

Cowen & Co. Maintains Outperform on Ichor Hldgs, Raises Price Target to $40

By Benzinga Newsdesk

Today, 11:24 AM

Cowen & Co. analyst Krish Sankar maintains Ichor Hldgs (NASDAQ:ICHR) with a Outperform and raises the price target from $32 to $40.

ICHR

Tesla Rival Rivian’s Investor Soros Wants The EV Maker To Price Its IPO Below The Reported $80B: Here’s Why

By Rachit Vats

Today, 11:24 AM

Rivian Automotive Inc investor Soros Fund Management LLC hopes the Amazon.com Inc (NASDAQ: AMZN)-backed electric automaker seeks a valuation lower than the expected $80 billion when pricing its initial public offering, Bloomberg N

AMZN

Over 50 Democrats Call To Repeal Fossil Fuel

By Benzinga Newsdesk

Today, 11:24 AM

-Bloomberg

SPY

Psychemedics Q1 EPS $0.01, Same YoY

Related Posts

Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $150

Cowen & Co. Maintains Outperform on Ichor Hldgs, Raises Price Target to $40

Tesla Rival Rivian’s Investor Soros Wants The EV Maker To Price Its IPO Below The Reported $80B: Here’s Why

Over 50 Democrats Call To Repeal Fossil Fuel